Skip to main content
Epocrates Online
Contact us
Explore features
Reach clinicians
Buy now
By
hgreaney@athen…
, 16 September, 2021
vancomycin
By
hgreaney@athen…
, 16 September, 2021
metronidazole
By
hgreaney@athen…
, 16 September, 2021
fidaxomicin
By
hgreaney@athen…
, 16 September, 2021
bezlotoxumab
By
hgreaney@athen…
, 16 September, 2021
View epocrates drug info
By
hgreaney@athen…
, 16 September, 2021
Recommended tx options:<sup>1-3,5</sup>
By
hgreaney@athen…
, 16 September, 2021
Recommended tx options 1 3 5 C Diff Table 3 20210903
By
hgreaney@athen…
, 16 September, 2021
Don t use rifaximin2
By
hgreaney@athen…
, 16 September, 2021
Don t stop antisecretory tx provided appropriate indication2
By
hgreaney@athen…
, 16 September, 2021
Don t recommend probiotics for prevention of recurrence2
Pagination
First page
Previous page
…
Page
980
Page
981
Page
982
Page
983
Current page
984
Page
985
Page
986
Page
987
Page
988
…
Next page
Last page
About Us
Company Overview
Media Relations
Contact
Editorial Policy
Editorial Process
Third-Party Sponsorship Policy
athenahealth
Products
Core Products
Mobile CME
Product Licenses
Business Solutions
Pharma
Market Research
Institutions
Support
Support Center
Install
My Account
Stay Connected
Facebook
Twitter
YouTube
